OnKure Therapeutics, Inc. SEC filings OKUR
OnKure Therapeutics, Inc. has 404 filings in SEC EDGAR's recent list, going back to Jan 8, 2018. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2026 | Aug 7, 2026 |
| 424B5 | Prospectus supplement | Aug 4, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| EFFECT | Filing | May 4, 2026 | — |
| CORRESP | Letter to the SEC | Apr 30, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2026 | — |
| S-3 | Shelf registration | Apr 24, 2026 | — |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 3, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Mar 30, 2026 | Mar 27, 2026 |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| EFFECT | Filing | Nov 18, 2025 | — |
| POS AM | Filing | Nov 6, 2025 | — |
| S-3 | Shelf registration | Nov 6, 2025 | — |
| 424B3 | Prospectus | Nov 6, 2025 | — |
| 8-K |
Current report
Material agreement
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2025 | Jun 26, 2025 |
| 424B3 | Prospectus | May 28, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 27, 2025 |
| 424B3 | Prospectus | May 6, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | May 27, 2025 |
| ARS | Annual report to shareholders | Apr 16, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | Mar 24, 2025 | — |
| EFFECT | Filing | Mar 21, 2025 | — |
| POS AM | Filing | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 10, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | Dec 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| S-8 | Employee stock plan registration | Dec 9, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 8-K |
Current report
Auditor change, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 424B3 | Prospectus | Oct 31, 2024 | — |
| EFFECT | Filing | Oct 30, 2024 | — |
| CORRESP | Letter to the SEC | Oct 28, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2024 | — |
| S-1 | Registration statement | Oct 23, 2024 | — |
| D | Filing | Oct 21, 2024 | — |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 8, 2024 | Oct 4, 2024 |
| 425 | Filing | Oct 2, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 2, 2024 | Sep 26, 2024 |
| 425 | Filing | Sep 20, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 20, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2024 | Sep 9, 2024 |
| EFFECT | Filing | Aug 26, 2024 | — |
| 424B3 | Prospectus | Aug 26, 2024 | — |
| S-4/A | Filing | Aug 26, 2024 | — |
| CORRESP | Letter to the SEC | Aug 23, 2024 | — |
| CORRESP | Letter to the SEC | Aug 19, 2024 | — |
| S-4/A | Filing | Aug 19, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 425 | Filing | Aug 13, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| UPLOAD | Letter from the SEC | Aug 12, 2024 | — |
| S-4/A | Filing | Jul 29, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| S-4 | Registration for a merger or exchange | Jun 21, 2024 | — |
| 425 | Filing | May 13, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
May 13, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 10-K/A | Amended annual report | Apr 26, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Feb 23, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Dec 14, 2023 | Dec 14, 2023 |
| EFFECT | Filing | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| S-3 | Shelf registration | Nov 13, 2023 | — |
| 424B5 | Prospectus supplement | Nov 13, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 10, 2023 | Oct 9, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| EFFECT | Filing | Jun 13, 2023 | — |
| CORRESP | Letter to the SEC | Jun 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| S-3 | Shelf registration | Jun 5, 2023 | — |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 5, 2023 | May 5, 2023 |
| 424B5 | Prospectus supplement | May 4, 2023 | — |
| 424B5 | Prospectus supplement | May 3, 2023 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
May 3, 2023 | May 3, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | Jun 6, 2023 |
| S-8 | Employee stock plan registration | Mar 27, 2023 | — |
| 10-K | Annual report | Mar 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Other events
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2022 | Jun 1, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| EFFECT | Filing | May 9, 2022 | — |
| CORRESP | Letter to the SEC | May 5, 2022 | — |
| UPLOAD | Letter from the SEC | May 4, 2022 | — |
| S-3 | Shelf registration | May 2, 2022 | — |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 1, 2022 |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| 10-K | Annual report | Mar 23, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2022 | Feb 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 24, 2022 | Jan 18, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 27, 2021 | Dec 23, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2021 | Oct 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2021 | Aug 11, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 10-Q | Quarterly report | May 20, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 20, 2021 | May 20, 2021 |
| 8-K |
Current report
Officer or director change
|
May 14, 2021 | May 11, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Apr 13, 2021 | Apr 13, 2021 |
| 424B4 | Prospectus | Apr 9, 2021 | — |
| S-8 | Employee stock plan registration | Apr 9, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 8, 2021 | — |
| EFFECT | Filing | Apr 8, 2021 | — |
| CERT | Filing | Apr 8, 2021 | — |
| 8-A12B | Filing | Apr 6, 2021 | — |
| CORRESP | Letter to the SEC | Apr 6, 2021 | — |
| CORRESP | Letter to the SEC | Apr 6, 2021 | — |
| S-1/A | Amended registration statement | Apr 5, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| CORRESP | Letter to the SEC | Mar 19, 2021 | — |
| S-1 | Registration statement | Mar 19, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2021 | — |
| DRS | Filing | Feb 12, 2021 | — |
| D | Filing | Dec 21, 2020 | — |
| D | Filing | May 14, 2019 | — |
| D | Filing | Jan 8, 2018 | — |
Showing 169 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OKUR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1637715
- Former names
- Reneo Pharmaceuticals, Inc. (until Oct 2, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.